期刊文献+

肺腺癌A_(549)/DDP细胞周期变化及其多药耐药性 被引量:4

Change of Cell Cycle and Resistance of A_( 549) Cells to Cisplatin.
下载PDF
导出
摘要 用Fura 2 /AM标记药物敏感的肺腺癌细胞A54 9和抗顺铂药物的肺腺癌细胞A54 9/DDP两种细胞胞内游离Ca2 +,用碘化丙锭 (PI)标记细胞DNA ,检测其胞内Ca2 +的变化及两种细胞增殖能力和细胞周期 .实验结果表明 ,抗药性细胞株A54 9/DDP胞浆内游离Ca2 +的浓度仅为药物敏感细胞株A54 9的 1/ 3左右 ,同时前者的细胞增殖能力较后者明显增强 ,而且细胞周期也明显缩短 .当用BAPTA AM和EGTA或A2 3187和Thapsigargin处理细胞以降低或升高其胞内自由Ca2 +浓度时可改变细胞的生长周期 ,二者也呈现明显差别 .这些结果表明 ,对顺铂产生耐药性的人肺腺癌A54 9/DDP细胞胞内Ca2 +浓度的降低 ,可能影响细胞的增殖 ,缩短细胞的生长周期 ,特别是影响起决定作用的G1期 。 The change of intracellular free Ca 2+ in A 549 cells sensitive and A 549 /DDP cells resistant to the cis dichlorodiammine platinum (cisplatin) were measured by Fura 2/AM, the proliferation ability and cell cycle were measured by propidium iodide(PI) labeling cellular nuclear DNA. The results indicated that the concentration of intracellular free calcium of the sensitive A 549 cells was 2 times higher than that of the resistant A 549 /DDP cells; the proliferation ability of the latter increased significantly than that of the former, the cell cycle also shortened. The proliferation ability and cell cycle of the two cell lines also clearly showed difference by decreasing or increasing their intracellular free calcium concentration if the cells were treated with BAPTA AM or EGTA and A 23187 or Thapsigargin. All of the results demonstrated that the concentration decrease of intracellular free calcium in the A 549 /DDP cells resistant to cisplatin may affect the cellular proliferation, shorten the cellular cycle, which would be helpful to remain the multidrug resistance characteristics of A 549 /DDP cells by specially modulating the cellular decisive G1 of cell cycle.
出处 《生物化学与生物物理进展》 SCIE CAS CSCD 北大核心 2000年第6期616-620,共5页 Progress In Biochemistry and Biophysics
基金 中国科学院重大项目!(KJ951 B1 60 9) 国家自然科学基金委重点项目资助!(39730 1 30 )
关键词 多药耐药性 细胞周期 肺腺癌细胞A549 multidrug resistance, intracellular free Ca^( 2+) , cell cycle, lung adenocarcinoma cancer A_ (549) cells
  • 相关文献

参考文献5

  • 1Liang X J,Biosci Rep,2000年,20卷,3期,129页
  • 2Yang X Y,Biosci Rep,2000年,20卷,1期,1页
  • 3Jan C R,Life Sci,1999年,64卷,4期,259页
  • 4Takuwa N,Cellular Signaling,1995年,7卷,2期,93页
  • 5Lu K P,Endocrine Reviews,1993年,14卷,1期,40页

同被引文献52

  • 1蔡莉,王滨,苍柏.托瑞米芬协同EP方案对耐药非小细胞肺癌的影响[J].实用肿瘤学杂志,2004,18(3):166-168. 被引量:3
  • 2周彩存,张捷,郑迪,吕梅君,鲁冰,徐建芳.托瑞米芬联合长春地辛和顺铂化疗方案治疗不能手术切除的非小细胞肺癌[J].中华结核和呼吸杂志,2004,27(8):546-548. 被引量:8
  • 3臧旺福,陈云富,孙秀威,鄢凤昌,冯占军.女性肺癌对雌、孕激素受体的依赖及受体与预后的关系─附57例临床病理研究[J].肿瘤防治研究,1994,21(2):76-78. 被引量:14
  • 4Kim DH, Lee NY, Sung WJ, et al. Multidrug resistance as a potential prognostic indicator in acute myeloid leukemia with normal karyotypes [J]. Acta Haematol, 2005,114(2) : 78-83.
  • 5Del Poeta G, Stasi R, Aronica G, et al. Clinical relevance of P-glycoprotein expression in de novo acute myeloid leukemia [J]. Blood, 1996,87 (5):1997- 2004.
  • 6Kruh GD, Chan A, Myers K, et al. Expression complementary DNA library transfer establishes mrp as a multidrug resistance gene [J]. Cancer Res, 1994,54 (7) : 1649-1652.
  • 7Wada H, Saikawa Y, Niida Y, et al. Selectively induced high MRP gene expression in muhidrugresistant human HL60 leukemia cells [J]. Exp Hematol, 1999,27( 1 ) :99-109.
  • 8Schulman BA, Carrano AC, Jeffrey PD, et al. Insights into SCF ubiquitin ligases from the structure of the skp1-skp2 complex [J]. Nature, 2000,408(6810): 381-386.
  • 9Sutterluty H, Chatelain E, Marti A, et al. p45SKP2 promotes p27Kipl degradation and induces S phase in quiescent cells [ J ]. Nat Cell Biol, 1999,1 (4) : 207-214.
  • 10Agarwal A, Bumm TG, Corbin AS, et al. Absence of SKP2 expression attenuates BCR-ABL-induced myeloproliferative disease [J]. Blood, 2008, 112 (5) : 1960- 1970.

引证文献4

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部